GlassScriptPhysician profile
Bonnie M Kaas
NPI 1962772822
$1,041.67
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $46.36 · 2021: $11.60 · 2022: $58.44 · 2023: $282 · 2024: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $280.20 | 2021-2024 | |
| Medtronic USA, INC. | $249.85 | 2019 | |
| Amneal Pharmaceuticals LLC | $207.57 | 2023-2024 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Pfizer INC. | $138.54 | 2023-2024 | |
| Horizon Therapeutics Plc | $79.12 | 2023 | Uplizna |
| Allergan, INC. | $27.02 | 2020 | |
| Aucta Pharmaceuticals, INC. | $21.85 | 2024 | Motpoly Xr |
| Teva Pharmaceuticals USA, INC. | $19.34 | 2020 | |
| Lilly USA, LLC | $18.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bonnie Kaas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.